Skip to main content
Clinical Trials/NCT04944446
NCT04944446
Completed
Not Applicable

Effectiveness of Myofascial Release in Pathologies of the Shoulder

University of Cadiz1 site in 1 country44 target enrollmentSeptember 15, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Humerus Fracture
Sponsor
University of Cadiz
Enrollment
44
Locations
1
Primary Endpoint
Functional capacity
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Shoulder pathology has a high prevalence in the field of musculoskeletal diagnoses, as well as being a common etiology in cases of disability. Passive and active-assisted kinesitherapy are used in the physiotherapy protocol. These techniques sometimes lead to feedback of fear and increased sensation of pain on the part of the patient that can slow or hinder the optimal recovery. A randomized clinical trial is intended to demonstrate that techniques for myofascial release of muscles important in the biomechanics of the shoulder, it is more effective than kinesitherapy in improving myofascial and also by eliminating the aforementioned unwanted effects and, therefore, improving the recovery of these processes.

Detailed Description

The purpose of this study was to compare the efficacy of myofascial therapy and kinesitherapy in improving function in shoulder pathology with prolonged immobilization. Design Prospective, single-blind randomized controlled trial. Setting Inpatient department of a secondary university hospital. Participants Shoulder pain patients (N=44) were consecutively recruited and randomly assigned to an intervention or control group. Interventions Patients were randomly assigned to a Control Group, to which conventional kinesitherapy was applied, or to the intervention group to which a Myofascial therapy protocol was applied. Both groups completed a therapeutic exercise program based on specific mobilization and strengthening exercises. Main Outcome Measures The QuickDash questionnaire was the primary outcome, visual analog scale and the passive range of motion of the shoulder joint, grades were the secondary outcomes. The outcomes were evaluated at baseline (T0) and at 4 (T2),

Registry
clinicaltrials.gov
Start Date
September 15, 2018
End Date
January 15, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Be between 20 and 80 years old.
  • Patients who have been immobilized due to the following diagnoses: Suture of the rotator cuff or fracture of the proximal extremity of the humerus.
  • Have signed the informed consent of acceptance in the participation of the study

Exclusion Criteria

  • Present neurological pathology.
  • Be subdued corticoid therapy.
  • Have anticoagulant treatment or have had it less than a month ago.
  • Insulin-dependent diabetic patients.
  • Patients with hemophilia.
  • Having diagnosed a psychological or psychiatric pathology.
  • Non-intervened displaced humerus fractures.

Outcomes

Primary Outcomes

Functional capacity

Time Frame: Change from Baseline at 4 weeks

Dash Scale. Minimum: 0 Maximum: 100. Higher scores mean a worse outcome

Shoulder joint mobility

Time Frame: Change from Baseline at 4 weeks

Goniometer Records

Degree of pain

Time Frame: Change from Baseline at 4 weeks

Visual Analog Scale

Secondary Outcomes

  • Age(Baseline)
  • Sex(Baseline)
  • Pathology of access to the study(Baseline)

Study Sites (1)

Loading locations...

Similar Trials